Jason Amello - Mar 14, 2023 Form 4 Insider Report for Acer Therapeutics Inc. (ACER)

Role
Director
Signature
/s/ Harry S. Palmin, Attorney-in-Fact
Stock symbol
ACER
Transactions as of
Mar 14, 2023
Transactions value $
$0
Form type
4
Date filed
3/16/2023, 04:21 PM
Previous filing
Dec 12, 2022
Next filing
May 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACER Stock Option (right to buy) Award $0 +20K $0.00 20K Mar 14, 2023 Common Stock 20K $1.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option, which is made as part of the Issuer's 2023 annual compensation cycle, vests and becomes exercisable in full on March 14, 2024.